NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers prescription drug claims; dental claims; and claims for the extended health benefits, as well as a health care spending account that provides an amount of money to an individual to pay for health or dental benefits. The company also offers individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

NexgenRx Inc.

NexgenRx builds technology platforms for managing and self-managing group benefit plans, group pension plans, and patient support programs. The company offers software-as-a-service solutions for claims management, plan administration, and pension management.

NexgenRx

NexgenRx Inc. | 518 followers on LinkedIn. NexgenRx ™ a publicly traded company established in 2003, is Canada&#39;s only independent full-service Third-Party Administrator and Technology Solutions Provider, offering proprietary full front-end, eligibility, enrolment, hour bank and mobile access capabilities, together with state-of-the-art claims adjudication and full provider network coverage. These combined capabilities allow NexgenRx to provide Plan Sponsors, sophisticated administration and health benefit technology applications in a cost-effective SaaS (Software as a Service) Model.  
NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and plan members and deliver superior administration and claims processing solutions at a competitive cost.

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	7.19M -	8.16M 13.43%	9.32M 14.23%	9.28M 0.46%	10.03M 8.08%
cost of revenue	1.55M -	1.82M 17.27%	2.66M 46.47%	2.95M 11.09%	3.27M 10.71%
gross profit	5.64M -	6.34M 12.38%	6.66M 5.00%	6.32M 5.07%	6.76M 6.85%
selling and marketing expenses		261.79K -	215.14K 17.82%	614.18K 185.48%	533.46K 13.14%
general and administrative expenses		528.19K -	590.71K 11.84%	654.35K 10.77%	740.99K 13.24%
selling general and administrative expenses	5.74M -	5.16M 10.10%	4.96M 3.74%	6.26M 26.16%	7.29M 16.33%
research and development expenses
other expenses
cost and expenses	7.28M -	6.97M 4.28%	7.62M 9.33%	9.22M 20.90%	10.56M 14.53%
operating expenses	5.74M -	5.16M 10.10%	4.96M 3.74%	6.26M 26.16%	7.29M 16.33%
interest expense	288.72K -	273.33K 5.33%	149.73K 45.22%	113.01K 24.52%	28.93K 74.40%
ebitda	549.36K -	1.92M 249.63%	2.75M 43.23%	1.10M 60.16%	456.18K 58.38%
operating income	-92.82K -	1.19M 1,376.89%	1.70M 43.06%	59.10K 96.51%	-530.37K 997.35%
depreciation and amortization	642.18K -	735.47K 14.53%	1.06M 43.50%	1.04M 1.76%	986.54K 4.85%
total other income expenses net	-123.78K -	235.44K 290.20%	-106.63K 145.29%	40.09K 137.60%	300.20K 648.81%
income before tax	-216.61K -	1.42M 755.89%	1.59M 11.85%	99.20K 93.76%	-230.16K 332.03%
income tax expense	-56.26K -	-240.00K 326.63%	-1.59M 561.46%	115.72K 107.29%	20.31K 82.45%
net income	-160.35K -	1.66M 1,135.67%	3.18M 91.28%	-16.52K 100.52%	-250.47K 1,415.71%
weighted average shs out	69.92M -	69.92M 0%	74.84M 7.03%	70.34M 6.01%	70.53M 0.28%
weighted average shs out dil	69.92M -	69.92M 0%	74.84M 7.03%	70.34M 6.01%	70.53M 0.28%
eps	-0.00 -	0.02 1,134.78%	0.04 78.15%	-0.00 100.47%	-0.00 1,700%
epsdiluted	-0.00 -	0.02 1,134.78%	0.04 78.15%	-0.00 100.47%	-0.00 1,700%

NEGX

COM:NEXGENRX

NexgenRx

Last Close

0.20

18/11 20:00

Market Cap

13.48M

Beta: -

Volume Today

2.50K

Avg: -

Preview